Systemic therapy in non-conventional cancers of the larynx
Authors:
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 82, 61-68
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged SkinJournal of Clinical Oncology, 2013
- Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinomaJournal of the Chinese Medical Association, 2013
- Organ Preservation for Adenoid Cystic Carcinoma of the LarynxThe Oncologist, 2013
- Basaloid squamous cell carcinoma of the larynx—A systematic reviewAuris Nasus Larynx, 2012
- Transcriptionally‐active high‐risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas – a tissue microarray study utilizing E6/E7 mRNA in situ hybridizationHistopathology, 2012
- Clinical Features and Differential Diagnoses in Laryngeal Mucoepidermoid CarcinomaClinical Medicine Insights: Pathology, 2011
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic reviewThe Lancet Oncology, 2011
- Lymphoepithelial Carcinoma: Two Case Reports and a Systematic Review of Oral and Sinonasal CasesHead and Neck Pathology, 2011
- Verrucous carcinoma of the larynx: Determining the best treatment optionEuropean Journal of Surgical Oncology, 2006
- Mucoepidermoid Carcinoma of the LarynxORL, 1981